These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8205054)

  • 1. [The selectivity of the action of muscarinic agonists in vivo].
    Kosmachev AB; Kosmacheva IM; Iankhotova MV; Kuleshov VI
    Eksp Klin Farmakol; 1994; 57(2):6-8. PubMed ID: 8205054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
    Kosmachev AB; Titkova TA; Fil'ko OA; Libman NM
    Eksp Klin Farmakol; 2000; 63(4):13-6. PubMed ID: 11022298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The selectivity and protective properties of m-cholinolytics in dichlorodivinylphosphate poisoning].
    Kosmachev AB; Iankhotova MB; Kosmacheva IM
    Eksp Klin Farmakol; 1992; 55(3):56-8. PubMed ID: 1458168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of M-cholinomimetics on nociceptive stimulation in the spinal cord].
    Nemirovskiĭ AIu
    Farmakol Toksikol; 1985; 48(5):36-9. PubMed ID: 2866979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pH on muscarinic antagonist selectivity].
    Kosmachev AB; Iakhontova MB; Titkova TA; Fil'ko OA; Ramsh SM
    Eksp Klin Farmakol; 2001; 64(3):29-32. PubMed ID: 11558434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possible role of presynaptic effects in realizing the protective action of M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
    Kosmachev AB; Filippov VN; Kosmacheva IM; Khobotova ZI; Kuleshov VI
    Farmakol Toksikol; 1991; 54(4):67-9. PubMed ID: 1664807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of cholinoreceptors on the soma of RPa3 and LPa3 neurons in Helix lucorum].
    Pivovarov AS; Drozdova EI
    Neirofiziologiia; 1992; 24(1):77-86. PubMed ID: 1584310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive activity of muscarinomimetic agents.
    Kharkevich DA; Nemirovsky AYu
    Ann Ist Super Sanita; 1990; 26(1):11-5. PubMed ID: 2168137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice.
    Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L
    Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of drugs acting on the cholinergic muscarinic receptor. IV. Influence of cholinomimetics and cholinolytics injected into the lateral cerebral ventricle in the rat on concentrations of 5-HT and 5-HIAA.
    Kleinrok Z; Przegaliński E
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):497-503. PubMed ID: 1164151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivo.
    Wachtel H; Löschmann PA; Pietzuch P
    Pharmacopsychiatry; 1988 Sep; 21(5):218-21. PubMed ID: 3227052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of blockage of various M-cholinoreceptor subtypes in induction of tachycardia in rats].
    Kosmachev AB; Lychakov AV; Saunkina IuA; Fil'ko OA; Chigareva SM
    Eksp Klin Farmakol; 1997; 60(5):44-6. PubMed ID: 9483405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative sensitivity of the m-cholinoreceptors in various sites to cholinotropic agents].
    Angelova LA
    Farmakol Toksikol; 1985; 48(2):115-20. PubMed ID: 3996565
    [No Abstract]   [Full Text] [Related]  

  • 17. The cholinergic influences on aggression in isolated mice.
    Herbut M; Roliński Z
    Pol J Pharmacol Pharm; 1985; 37(1):1-10. PubMed ID: 4041036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The characteristics of the effect of imperialone on the M-cholinoreceptors of different organs].
    Mirzaev IuR; Plotnikova IT; Shakirov R
    Eksp Klin Farmakol; 1993; 56(4):14-7. PubMed ID: 8220005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The biochemical antagonism of cholinolytics and cholinomimetics at the level of the opiate system].
    Zhila VA; Gatsenko GN; Gromov LA
    Farmakol Toksikol; 1991; 54(6):14-6. PubMed ID: 1804683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
    Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
    J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.